Study: NCT04022304

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Biocon Insulin N
Description: Biocon Insulin N is an intermediate-acting isophane suspension of human insulin produced by recombinant deoxyribonucleic acid(rDNA) technology utilizing Pichia pastoris (yeast).

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Biocon Insulin N
Description: Biocon Insulin N is an intermediate-acting isophane suspension of human insulin produced by recombinant deoxyribonucleic acid(rDNA) technology utilizing Pichia pastoris (yeast).

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Biocon Insulin N
Description: Biocon Insulin N is an intermediate-acting isophane suspension of human insulin produced by recombinant deoxyribonucleic acid(rDNA) technology utilizing Pichia pastoris (yeast).

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Biocon Insulin N
Description: Biocon Insulin N is an intermediate-acting isophane suspension of human insulin produced by recombinant deoxyribonucleic acid(rDNA) technology utilizing Pichia pastoris (yeast).

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Biocon Insulin N
Description: Biocon Insulin N is an intermediate-acting isophane suspension of human insulin produced by recombinant deoxyribonucleic acid(rDNA) technology utilizing Pichia pastoris (yeast).

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Biocon Insulin N
Description: Biocon Insulin N is an intermediate-acting isophane suspension of human insulin produced by recombinant deoxyribonucleic acid(rDNA) technology utilizing Pichia pastoris (yeast).

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Humulin® N
Description: Humulin® N (human insulin \[recombinant deoxyribonucleic acid origin\] isophane suspension) is an intermediate-acting human isophane insulin. Humulin® N is a suspension of crystals produced from combining human insulin and protamine sulphate.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Humulin® N
Description: Humulin® N (human insulin \[recombinant deoxyribonucleic acid origin\] isophane suspension) is an intermediate-acting human isophane insulin. Humulin® N is a suspension of crystals produced from combining human insulin and protamine sulphate.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Humulin® N
Description: Humulin® N (human insulin \[recombinant deoxyribonucleic acid origin\] isophane suspension) is an intermediate-acting human isophane insulin. Humulin® N is a suspension of crystals produced from combining human insulin and protamine sulphate.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Humulin® N
Description: Humulin® N (human insulin \[recombinant deoxyribonucleic acid origin\] isophane suspension) is an intermediate-acting human isophane insulin. Humulin® N is a suspension of crystals produced from combining human insulin and protamine sulphate.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Humulin® N
Description: Humulin® N (human insulin \[recombinant deoxyribonucleic acid origin\] isophane suspension) is an intermediate-acting human isophane insulin. Humulin® N is a suspension of crystals produced from combining human insulin and protamine sulphate.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Humulin® N
Description: Humulin® N (human insulin \[recombinant deoxyribonucleic acid origin\] isophane suspension) is an intermediate-acting human isophane insulin. Humulin® N is a suspension of crystals produced from combining human insulin and protamine sulphate.